Evidence map›Paper›PMID 33668633›Full record

ReviewJournal of clinical medicine2021

Jason W Lee, Tobi Somerville, Stephen B Kaye, Vito Romano

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. α-hemolysin polymorphisms in methicillin-resistantbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  8. Evaluation ofCurrent drug delivery · 2025
    Article
  9. Article
  10. A comparison of antimicrobial regimen outcomes and antibiogram development in microbial keratitis: a prospective cohort study in Alexandria, Egypt.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  11. Article
  12. Frontiers in cellular and infection microbiology · 2023
    Review
  13. Article
  14. Identification ofAntibiotics (Basel, Switzerland) · 2022
    Article
  15. Anti-PeerJ · 2022
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jason W LeeSchool of Medicine, University of Liverpool, Liverpool L69 3GE, UK.
Tobi SomervilleDepartment of Eye and Vision Science, University of Liverpool, Liverpool L7 8TX, UK.
Stephen B KayeDepartment of Eye and Vision Science, University of Liverpool, Liverpool L7 8TX, UK.
Vito RomanoDepartment of Eye and Vision Science, University of Liverpool, Liverpool L7 8TX, UK.
University of Liverpool · GBRoyal Liverpool University Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial keratitis is a devastating condition that can rapidly progress to serious complications if not treated promptly. Certain causative microorganisms such as

Indexed as

keratitismicrobial keratitisnovel therapypathophysiologyStaphylococcus aureustherapeuticstreatment

Identifiers

PMID33668633
PMCPMC7918096
OpenAlexW3130250111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.